Welcia Holdings Co., Ltd. (WLCGF)
USD 16.41
(0.0%)
USD 16.41
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 307.48 Billion JPY | 0.83% |
| 2023 | 304.97 Billion JPY | 19.52% |
| 2022 | 255.15 Billion JPY | -0.07% |
| 2021 | 255.32 Billion JPY | 12.19% |
| 2020 | 227.58 Billion JPY | 24.04% |
| 2019 | 183.47 Billion JPY | 13.43% |
| 2018 | 161.75 Billion JPY | 21.94% |
| 2017 | 132.64 Billion JPY | 6.59% |
| 2016 | 124.44 Billion JPY | 35.85% |
| 2015 | 91.6 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 316.9 Billion JPY | -0.87% |
| 2024 Q3 | 312.9 Billion JPY | -1.26% |
| 2024 Q1 | 319.68 Billion JPY | 4.82% |
| 2024 FY | 307.48 Billion JPY | 0.82% |
| 2024 Q4 | 307.48 Billion JPY | -1.73% |
| 2023 Q1 | 281.72 Billion JPY | 10.41% |
| 2023 FY | 304.97 Billion JPY | 19.52% |
| 2023 Q4 | 304.97 Billion JPY | -2.36% |
| 2023 Q2 | 310.9 Billion JPY | 10.36% |
| 2023 Q3 | 312.35 Billion JPY | 0.47% |
| 2022 Q2 | 230.43 Billion JPY | -0.19% |
| 2022 FY | 255.15 Billion JPY | -0.07% |
| 2022 Q4 | 255.15 Billion JPY | 5.98% |
| 2022 Q3 | 240.75 Billion JPY | 4.48% |
| 2022 Q1 | 230.86 Billion JPY | -9.58% |
| 2021 Q4 | 255.33 Billion JPY | 14.47% |
| 2021 Q1 | 242.05 Billion JPY | 6.36% |
| 2021 Q3 | 223.06 Billion JPY | 4.18% |
| 2021 FY | 255.32 Billion JPY | 12.19% |
| 2021 Q2 | 214.11 Billion JPY | -11.54% |
| 2020 Q4 | 227.58 Billion JPY | 2.17% |
| 2020 FY | 227.58 Billion JPY | 24.04% |
| 2020 Q2 | 218.45 Billion JPY | 12.64% |
| 2020 Q3 | 222.76 Billion JPY | 1.97% |
| 2020 Q1 | 193.94 Billion JPY | 5.67% |
| 2019 Q1 | 173.31 Billion JPY | 7.15% |
| 2019 Q4 | 183.54 Billion JPY | 1.05% |
| 2019 FY | 183.47 Billion JPY | 13.43% |
| 2019 Q2 | 171.68 Billion JPY | -0.94% |
| 2019 Q3 | 181.63 Billion JPY | 5.79% |
| 2018 Q4 | 161.75 Billion JPY | 0.66% |
| 2018 FY | 161.75 Billion JPY | 21.94% |
| 2018 Q2 | 147.94 Billion JPY | 6.98% |
| 2018 Q3 | 160.69 Billion JPY | 8.62% |
| 2018 Q1 | 138.29 Billion JPY | 5.74% |
| 2017 Q3 | 128.51 Billion JPY | 3.39% |
| 2017 Q4 | 130.79 Billion JPY | 1.77% |
| 2017 FY | 132.64 Billion JPY | 6.59% |
| 2017 Q1 | 127.54 Billion JPY | 3.5% |
| 2017 Q2 | 124.3 Billion JPY | -2.54% |
| 2016 Q3 | 129.9 Billion JPY | 34.61% |
| 2016 Q1 | 113.02 Billion JPY | 0.0% |
| 2016 Q4 | 123.22 Billion JPY | -5.14% |
| 2016 FY | 124.44 Billion JPY | 35.85% |
| 2016 Q2 | 96.5 Billion JPY | -14.62% |
| 2015 Q2 | 94.54 Billion JPY | 0.6% |
| 2015 Q3 | 95.32 Billion JPY | 0.82% |
| 2015 FY | 91.6 Billion JPY | 0.0% |
| 2015 Q1 | 93.98 Billion JPY | 25.13% |
| 2014 Q3 | 90.46 Billion JPY | 0.0% |
| 2014 Q4 | 75.1 Billion JPY | -16.97% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | 3.15 Million USD | -9751208.942% |
| Allstar Health Brands, Inc. | 9.3 Million USD | -3304934.064% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 52.97 Million USD | -580363.063% |
| Café Serendipity Holdings, Inc. | 1.31 Million USD | -23333251.039% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 543.26 Thousand USD | -56600294.284% |
| HealthWarehouse.com, Inc. | 7.21 Million USD | -4261896.737% |
| LIGAND PHARMACEUTICAL INC | 86.3 Million USD | -356190.048% |
| MedGen, Inc. | 43.63 USD | -704765069806.028% |
| Omni Health, Inc. | 1.94 Million USD | -15836640.286% |
| Oxford Investments Holdings Inc. | 1.01 Million USD | -30230347.82% |
| Pineapple, Inc. | 10.61 Million USD | -2896108.967% |
| ScripsAmerica, Inc. | 9.16 Million USD | -3354133.226% |